Drug Chatter -- Tracking biopharma stock chatter

Profile for BioLineRx Ltd. (BLRX)

« Back to company index

BLRX Chatter Timeline

Stock Ticker for BLRX

Most Active Tweeters for BLRX

UserTweets
@fezziwig2008 6
@CentTrader1 6
@registrarjourn 5
@TranscriptDaily 5
@AmericanBanking 5

Recent Tweets for BLRX

WatchlistN @WatchlistN
BioLineRx $BLRX Stock Rating Upgraded by Zacks Investment Research https://t.co/0MW5Xbjz0b
May 25th 2018, 6:05pm
ThisLincolnian @ThisLincolnian
BioLineRx $BLRX Stock Rating Upgraded by Zacks Investment Research https://t.co/T0Z9gpiWgH
May 25th 2018, 6:05pm
TheMarketsDaily @TheMarketsDaily
Q2 2018 Earnings Forecast for BioLineRx Issued By Oppenheimer $BLRX https://t.co/pUEvfmCJcO
May 25th 2018, 6:05am
TranscriptDaily @TranscriptDaily
BioLineRx $BLRX Given a $4.00 Price Target at HC Wainwright https://t.co/vjiPj2rPI6
May 25th 2018, 4:05am
TickerReport @TickerReport
HC Wainwright Analysts Give BioLineRx $BLRX a $4.00 Price Target https://t.co/BV659KDf1t
May 25th 2018, 4:05am
ZolmaxNews @ZolmaxNews
Oppenheimer Research Analysts Increase Earnings Estimates for BioLineRx $BLRX https://t.co/hnYNcxswGw
May 25th 2018, 3:05am
dailypoliticaln @dailypoliticaln
Oppenheimer Research Analysts Increase Earnings Estimates for BioLineRx $BLRX https://t.co/hh1V9ksnM7
May 25th 2018, 3:05am
OlympiaReport @OlympiaReport
BioLineRx $BLRX Announces Quarterly Earnings Results, Beats Expectations By $0.01 EPS https://t.co/oOGZRFlMiI
May 24th 2018, 1:05pm
dispatchtribune @dispatchtribune
BioLineRx $BLRX Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPS https://t.co/FkJEBsrsdV
May 24th 2018, 1:05pm
keitrader @keitrader
@s_cwl $BLRX ~ should move into the data by Mid-2018 from the lead-in part of the Phase 3 GENESIS study in stem-cel… https://t.co/IJJSxSVeya
May 24th 2018, 12:05pm
keitrader @keitrader
$BLRX ~ anyone in?
May 24th 2018, 12:05pm
registrarjourn @registrarjourn
Oppenheimer Brokers Increase Earnings Estimates for BioLineRx $BLRX https://t.co/KkTe0UKEAS
May 24th 2018, 9:05am
TranscriptDaily @TranscriptDaily
Oppenheimer Brokers Increase Earnings Estimates for BioLineRx $BLRX https://t.co/ShbryH8cYU
May 24th 2018, 9:05am
registrarjourn @registrarjourn
BioLineRx $BLRX PT Set at $4.00 by HC Wainwright https://t.co/nxqWvvPjdb
May 24th 2018, 6:05am
dispatchtribune @dispatchtribune
BioLineRx $BLRX Expected to Post Earnings of -$0.08 Per Share https://t.co/8VwuJsVt2W
May 23rd 2018, 4:05pm
registrarjourn @registrarjourn
Brokerages Anticipate BioLineRx $BLRX Will Post Earnings of -$0.08 Per Share https://t.co/oskaT9iuUy
May 23rd 2018, 4:05pm
dailypoliticaln @dailypoliticaln
BioLineRx $BLRX Posts Quarterly Earnings Results, Beats Expectations By $0.01 EPS https://t.co/1mOYAW5ZfC
May 23rd 2018, 11:05am
ledgerzette @ledgerzette
BioLineRx $BLRX Given a $4.00 Price Target at HC Wainwright https://t.co/NUEZZyddhw
May 23rd 2018, 6:05am
ConsumerFeed @ConsumerFeed
BioLineRx $BLRX Given a $4.00 Price Target at HC Wainwright https://t.co/DkwTQy52cJ
May 23rd 2018, 5:05am
BridgeGameWWII @BridgeGameWWII
@FaisamTrader Hope $BLRX doesn’t act like $FWP. Slow Motion For Me.
May 22nd 2018, 8:05pm
dbuello @dbuello
$BLRX has a lot coming up on the horizon. You don’t often get a company of this size with this many catalysts. This… https://t.co/H5os17sdtH
May 22nd 2018, 4:05pm
dbuello @dbuello
RT @Kevin_W81: $BLRX ?? P3 GENESIS study mid 2018 (autologous transplantation in multiple myeloma) ?? P2a COMBAT study 2H 2018 (in combo…
May 22nd 2018, 4:05pm
WeekHerald @WeekHerald
BioLineRx $BLRX Given a $4.00 Price Target by HC Wainwright Analysts https://t.co/aov0pSWUEA
May 22nd 2018, 3:05pm
AmericanBanking @AmericanBanking
HC Wainwright Analysts Give BioLineRx $BLRX a $4.00 Price Target https://t.co/bUdawjP2Of #stocks
May 22nd 2018, 2:05pm
ThisLincolnian @ThisLincolnian
BioLineRx $BLRX Releases Earnings Results, Beats Expectations By $0.01 EPS https://t.co/G1Juv5bP5z
May 22nd 2018, 2:05pm
dailypoliticaln @dailypoliticaln
BioLineRx $BLRX Given a $4.00 Price Target by HC Wainwright Analysts https://t.co/IAOOchcrmU
May 22nd 2018, 2:05pm
ZolmaxNews @ZolmaxNews
BioLineRx $BLRX Given a $4.00 Price Target by HC Wainwright Analysts https://t.co/ACPVSLfUAc
May 22nd 2018, 2:05pm
WatchlistN @WatchlistN
BioLineRx $BLRX Releases Earnings Results, Beats Expectations By $0.01 EPS https://t.co/Ym8lUp9UtF
May 22nd 2018, 1:05pm
TickerReport @TickerReport
BioLineRx $BLRX Announces Earnings Results https://t.co/p5Ay8dwtMR
May 22nd 2018, 1:05pm
AmericanBanking @AmericanBanking
BioLineRx $BLRX Announces Quarterly Earnings Results, Beats Expectations By $0.01 EPS https://t.co/HlS4vQL07z #stocks
May 22nd 2018, 1:05pm
registrarjourn @registrarjourn
BioLineRx $BLRX Announces Quarterly Earnings Results, Beats Expectations By $0.01 EPS https://t.co/cs0DHTrcIX
May 22nd 2018, 1:05pm
PCGAdvisory @PCGAdvisory
$BLRX BioLineRx Reports First Quarter 2018 Financial Resultshttps://buff.ly/2ID3Vhb
May 22nd 2018, 12:05pm
ARatings @ARatings
H.C. Wainwright Remains a Buy on Biolinerx $BLRX https://t.co/aHbOdPINsR
May 22nd 2018, 12:05pm
JasonMilano8 @JasonMilano8
$BLRX Bought some this morning. I like what CEO is doing here. Collaborations with major big pharma like Genentech & Merck
May 22nd 2018, 11:05am
Kevin_W81 @Kevin_W81
RT @BioStocks: $BLRX data from the lead-in part of the Phase 3 GENESIS study in stem-cell mobilization for autologous transplantation by mi…
May 22nd 2018, 11:05am
Kevin_W81 @Kevin_W81
$BLRX ?? P3 GENESIS study mid 2018 (autologous transplantation in multiple myeloma) ?? P2a COMBAT study 2H 2018 (… https://t.co/dQSv20Phio
May 22nd 2018, 10:05am
BioRunUp @BioRunUp
$BLRX - Ph3 lead in data by mid year 2018 per this mornings PR https://t.co/uymXWAerQU
May 22nd 2018, 10:05am
smallcaps88 @smallcaps88
$BLRX now 1
May 22nd 2018, 10:05am
smallcaps88 @smallcaps88
$BLRX next leg
May 22nd 2018, 10:05am
StockNewsNow @StockNewsNow
$BLRX BioLineRx Reports First Quarter 2018 Financial Results https://t.co/LAUmwhnliq
May 22nd 2018, 9:05am
bdailystocks @bdailystocks
$BLRX 's Numbers Revealed https://t.co/QVGmc88E8q
May 22nd 2018, 8:05am
Stock_News_Now @Stock_News_Now
$BLRX: New SEC Filing for BLRX: Form 6-K (No. 0001178913-18-001719): https://t.co/62DO7TtpCG
May 22nd 2018, 8:05am
MarketCurrents @MarketCurrents
Biolinerx reports Q1 result https://t.co/6Ec9uFhDzO #premarket $BLRX
May 22nd 2018, 7:05am
PRNewswireIL @PRNewswireIL
#BioLineRx Reports First #Quarter 2018 #Financial #Results https://t.co/4fSHh95AHr @BioLineRx_Ltd $BLRX
May 22nd 2018, 7:05am
CentTrader1 @CentTrader1
$BLRX BioLineRx Reports First Quarter 2018 Financial Results https://t.co/oYh9X9sU2L $BLRX
May 22nd 2018, 7:05am
StockTexts @StockTexts
$BLRX BioLineRx Ltd. SEC Filing: Form 6-K https://t.co/oJoQrcIFWa
May 22nd 2018, 7:05am
BioStocks @BioStocks
$BLRX data from the lead-in part of the Phase 3 GENESIS study in stem-cell mobilization for autologous transplantation by mid-year 2018
May 22nd 2018, 7:05am
MarketCurrents @MarketCurrents
biolinerx beats by $0.01 https://t.co/M3sISH5bMv #premarket $BLRX
May 22nd 2018, 7:05am
stockfollower4u @stockfollower4u
BioLineRx Ltd. $BLRX Stock Live Analysis 04-21-2017 #stock https://t.co/8UQoEnp1B6
May 22nd 2018, 1:05am
TheMarketsDaily @TheMarketsDaily
Zacks: Brokerages Anticipate BioLineRx $BLRX to Announce -$0.07 Earnings Per Share https://t.co/vAW2ygCmNt
May 21st 2018, 11:05am

Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.